Kaneka Eurogentec vs Pfizer CentreOne: CDMO Comparison
How does Kaneka Eurogentec compare to Pfizer CentreOne for mRNA/LNP manufacturing?
Side-by-side comparison of Kaneka Eurogentec and Pfizer CentreOne on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Pfizer CentreOne has more FDA inspections on record (4 vs 1) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Pfizer CentreOne has materially broader EMA GMP coverage (14 active certificates vs 4) — stronger EU footprint.
- Pfizer CentreOne appears as a manufacturing partner on more matched clinical programs (369 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both Kaneka Eurogentec and Pfizer CentreOne qualify as mRNA/LNP manufacturers; Pfizer CentreOne carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both Kaneka Eurogentec and Pfizer CentreOne qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: Kaneka Eurogentec vs Pfizer CentreOne
How does Kaneka Eurogentec compare to Pfizer CentreOne for mRNA/LNP manufacturing?
On CDMO Signal's composite Signal Score, Kaneka Eurogentec is 82/100 and Pfizer CentreOne is 89/100; Kaneka Eurogentec has 1 FDA inspection on record vs 4 for Pfizer CentreOne; European coverage is 4 active EMA+MHRA certificates for Kaneka Eurogentec vs 14 for Pfizer CentreOne. Both are tracked in the CDMO Signal directory as mRNA/LNP CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, Kaneka Eurogentec or Pfizer CentreOne?
Both Kaneka Eurogentec and Pfizer CentreOne maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Kaneka Eurogentec has 1 FDA inspection on record; Pfizer CentreOne has 4.
How do Kaneka Eurogentec and Pfizer CentreOne compare on European GMP coverage?
Kaneka Eurogentec holds 4 active EMA GMP certificates and 0 MHRA / UK certificates. Pfizer CentreOne holds 14 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Kaneka Eurogentec or Pfizer CentreOne?
Kaneka Eurogentec is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Pfizer CentreOne is matched to 369. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for mRNA/LNP manufacturing — Kaneka Eurogentec or Pfizer CentreOne?
Both Kaneka Eurogentec and Pfizer CentreOne are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →